CClinicalTrials.gg
Enrolling by invitationNCT06649929Updated Aug 7, 2026

Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples With Implications for Alzheimer's Disease Risk

A Phase 2 interventional study of Couples-based treatment- Patient and Couples-based treatment- Partner in Sleep Apnea and Sleep Disturbance, sponsored by University of Utah. Enrolling by invitation at 2 sites in United States. Open to participants aged 35 Years and older. Per ClinicalTrials.gov, last updated 2026-08-07.

Sponsored by University of Utah · Phase 2, Interventional, and Other

Phase
Phase 2
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
35 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if the culturally adapted couples sleep health intervention (Nuestro Sueno) improves positive airway pressure use and sleep among Hispanic couples in which one partner was diagnosed with sleep apnea and starting positive airway pressure treatment.

The main questions are:

  1. Does Nuestro sueno improve the patient's positive airway pressure use over the first 3 months of using it compared to an information control?
  2. Does Nuestro sueno improve sleep quality for both the patient and partner, compared to an information control?
  3. Does Nuestro sueno improve other aspects of life including quality of life and memory, compared to an information control?
Read the detailed description

Latino adults in the United States are 1.5 times more likely to develop Alzheimer's disease and related dementias compared to non-Hispanic white adults. Obstructive sleep apnea affects 9.8% of Latino adults and confers a five-fold increased risk of Alzheimer's disease diagnosis. Consequences also extend to the bedpartner, as bedpartners of those with obstructive sleep apnea experience significant sleep disturbances, including sleep fragmentation and 3 times greater risk of insomnia. Given solid mechanistic links between both obstructive sleep apnea and insomnia and Alzheimer's Disease risk, effective obstructive sleep apnea treatment has the potential to promote healthy cognitive aging and reduce Alzheimer's Disease risk for both partners. While the front-line treatment for obstructive sleep apnea, positive airway pressure, is highly effective at reducing obstructive sleep apnea symptoms and may reduce or forestall Alzheimer's Disease risk, its potential is severely diminished, as up to 80% of patients are non-adherent. Extant positive airway pressure adherence interventions are limited in that they are exclusively focused on the individual, neglecting to consider the role of the bedpartner in treatment, and developed primarily in non-Hispanic white populations. Therefore, there is a critical need to develop evidence-based, and culturally-adapted interventions that address the impact of obstructive sleep apnea and its treatment on both partners and within a culturally-tailored framework. The goal of this study is to develop and test "Nuestro Sueño" a culturally-adapted intervention to promote positive airway pressure adherence and sleep health among Latino couples. This study will involve a randomized clinical trial to evaluate the feasibility, treatment satisfaction and preliminary efficacy of Nuestro Sueño versus information control in a sample of 80 patients with obstructive sleep apnea and their partners (i.e., 40 couples per treatment arm) across two sites (Utah and Arizona). The intervention focuses specifically on the interpersonal mechanisms of enhancing dyadic coping and communication, using intervention materials resonant with cultural beliefs and values. If successful, Nuestro Sueño, an innovative and culturally-adapted intervention, has the potential to significantly advance the treatment of obstructive sleep apnea, and may elucidate a critical, modifiable target of prevention and intervention to promote healthy aging and reduce disparities in Alzheimer's Disease risk among Latino couples.

02

Conditions studied

  • Sleep Apnea
  • Sleep Disturbance

Keywords

  • sleep
  • couples
  • positive airway pressure
03

In context

Sleep Apnea Syndromes

2,162 studies on the registry are indexed under Sleep Apnea Syndromes; 290 are open to participants now.

This study's planned enrollment of 80 is above the median of 53 across 1,386 interventional studies indexed under Sleep Apnea Syndromes.

Browse Sleep Apnea Syndromes studies →

Lead sponsor

University of Utah is the lead sponsor of 969 studies on the registry; 178 are open to participants now.

Of its 107 completed or terminated interventional studies of FDA-regulated products, 62 (58%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Patients inclusion criteria:

  • Self-reported Latino ethnicity
  • Age >35, 3)
  • Diagnosed with obstructive sleep apnea and intend to start PAP
  • Never used positive airway pressure or-restarting CPAP after 3 months
  • Married or cohabiting with a romantic partner for >1 year
  • Able to read/write English or Spanish
  • Access to cellular (active data plan) or Wi-Fi, or able to use study devices in order to complete the telehealth intervention.

Partner inclusion criteria:

  • Able to read/write in English or Spanish
  • Interested in improving their sleep (yes/no)
  • Access to cellular (active data plan) or Wi-Fi, to complete the telehealth intervention or able to use a study device.

Partners of all ethnicities will be invited to participate. The intervention will be delivered in couples preferred language.

Exclusion criteria for both patient and partner

  • High risk or presence of moderate to severe comorbid sleep disorders (i.e., restless legs syndrome)
  • History of cognitive or neurological or major psychiatric disorders
  • Unstable or serious medical illness that would interfere with participation (cancer, renal disease on dialysis, moderate to severe chronic obstructive pulmonary disease
  • Patients with need for more complex care (e.g., adaptive servo-ventilation, supplemental oxygen) or concurrent sleep apnea treatment such as bariatric surgery or oral appliance
  • Overnight work > 1x per month; 7) Pregnancy/desire to become pregnant in the study period; 8) Current participation in behavioral sleep treatment (e.g., cognitive behavioral therapy for insomnia)
  • Concurrent participation in another clinical trial
  • Caregiving for an infant \< 2 years old or adult who requires overnight assistance
05

Study design

Phase
Phase 2
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Couples-based treatment- Patient

    In this group, couples will attend 3-telehealth based sessions with a community health worker for education and interventions to improve communication, sleep quality and PAP use

    Behavioral: Couples-based treatment- Patient

  • Experimental
    Couples-based treatment- Partner

    In this group, couples will attend 3-telehealth based sessions with a community health worker for education and interventions to improve communication, sleep quality and PAP use

    Behavioral: Couples-based treatment- Partner

  • Active comparator
    Information Control- Patient

    In this group, couples will recieve a standardized packet of insomnia about obstructive sleep apnea and starting positive airway pressure.

    Other: Information control- Patient

  • Active comparator
    Information Control- Partner

    In this group, couples will recieve a standardized packet of insomnia about obstructive sleep apnea and starting positive airway pressure.

    Other: Information control- Partner

Interventions

  • BehavioralCouples-based treatment- Patient

    couples will attend 3-telehealth based sessions to provide eduction, increase self-efficacy and teach skils based in principles of brief behavioral therapy for insomnia

  • BehavioralCouples-based treatment- Partner

    couples will attend 3-telehealth based sessions to provide eduction, increase self-efficacy and teach skils based in principles of brief behavioral therapy for insomnia

  • OtherInformation control- Patient

    Information only plus treatment as usual

  • OtherInformation control- Partner

    Information only plus treatment as usual

06

What researchers measure

Primary outcomes

  1. Recruitment Feasibility

    Defined as the ability to achieve the recruitment goals of the study, to recruit approximately 3-4 couples per month over the study period

    Time frame: 36 months

Secondary outcomes

  1. Proportion of Days With positive airway pressure Use of 4 Hours or More

    The primary efficacy measure for this pilot trial was the proportion of days that patients used CPAP for 4 hours or more over the first 3 months. This 4 hour cutoff was selected becasue it is the minimum usage defined by Medicare and other insurance companies. We obtained patients' CPAP usage by downloading data from their machine using a remote dashboard. Data are only available for patients because partners were not using the treatment. This variable is defined as a proportion, calculated as the number of days with CPAP usage of 4 hours or more divided by the total number of days collected in the 3 month recording period. Scores can range from 0 (no days with use to 1, indicating all days with use of 4 hours or more).

    Time frame: 3 months

  2. Self-reported Sleep Disturbance

    Patient sleep quality on the Patient-Reported Outcomes Measurement Information System (PROMIS) sleep disturbance scale, 8 item, version 8b. Models evaluated change from baseline to 3 months. Raw are converted to t-scores, with a range of 28.9-76.5, a mean of 50 and a SD of 10. Higher scores indicate poorer sleep subjective quality.

    Time frame: 3 months

Other outcomes

  1. Intervention Completion

    Percentage of participants who completed the intervention sessions: 3 sessions for the couples-based treatment group and 1 handout and phone call for the information control group

    Time frame: 1 month

  2. Retention

    We defined retention as the number of participants completing the 3 month follow-up. Our goal was to acheive at least 85% retention.

    Time frame: 3 months

07

Study locations

2 sites
  • Banner Health
    Tuscon, Arizona 85713, United States
  • University of Utah
    Salt Lake City, Utah 84108, United States
08

References and documents

Publications

  • Baron KG, Alcantara C, Lopez I, Euler M, Baucom BRW, Bermudez B, Arones Y, Carbajal-Salisbury S, Fabian G, Grandner M, Gorovoy S, Lopez S, Parthasarathy S, Troxel W. Protocol for Nuestro Sueno: A randomized trial of a couples-based intervention to improve PAP adherence and sleep health among Hispanic patients beginning positive airway pressure (PAP) and their partners. Sleep Med. 2026 Sep;145:109019. doi: 10.1016/j.sleep.2026.109019. Epub 2026 May 15. PubMed 42176392 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06649929
Lead sponsor
University of Utah
Collaborators
National Institute on Aging (NIA), University of Arizona, Banner Health
Responsible party
Kelly Glazer Baron (Professor, University of Utah) — Principal investigator
First posted
Oct 21, 2024
Start date
Mar 20, 2025
Primary completion
Nov 1, 2027 (estimated)
Completion
Mar 1, 2028 (estimated)
Last update
Aug 7, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion